1/2 mek inhibitors for the treatment of peritoneal fibrosis.

摘要

1/2 MEK inhibitors for the treatment of peritoneal fibrosis. # Drugs useful in the prevention and treatment of fibrosis of the peritoneal membrane (peritoneal opacification, suntan peritoneum syndrome, mural fibrosis and sclerosing peritonitis syndrome) produced as a result of long-term peritoneal dialysis, method of selecting these drugs, and method for collecting data useful in diagnosing the disease.